Wordt geladen...
Clinical decision making in the era of immunotherapy for high grade-glioma: report of four cases
BACKGROUND: Immune checkpoint inhibitors (ICPIs) are being investigated in clinical trials for patients with glioblastoma. While these therapies hold great promise, management of the patients receiving such treatment can be complicated due to the challenges in recognizing immune-related adverse even...
Bewaard in:
| Gepubliceerd in: | BMC Cancer |
|---|---|
| Hoofdauteurs: | , , , , , , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
BioMed Central
2018
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5831705/ https://ncbi.nlm.nih.gov/pubmed/29490632 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-018-4131-1 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|